End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 CAD | +0.61% | +0.41% | -6.62% |
08/06 | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
07/06 | J&J-backed Rapport Therapeutics shares debut nearly 6% higher | RE |
Sales 2024 * | 8.88TCr 12TCr 7,41400Cr | Sales 2025 * | 9.21TCr 13TCr 7,69100Cr | Capitalization | 35TCr 49TCr 29,55900Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.99 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.84 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,31,900 |
Yield 2024 * |
3.28% | Yield 2025 * |
3.43% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +0.61% | ||
1 week | +0.41% | ||
Current month | +0.41% | ||
1 month | -1.89% | ||
3 months | -7.80% | ||
6 months | -5.23% | ||
Current year | -6.62% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
07/24/07 | 19.75 | +0.61% | 5,894 |
06/24/06 | 19.63 | +0.20% | 1,034 |
05/24/05 | 19.59 | -1.16% | 4,776 |
04/24/04 | 19.82 | +0.10% | 5,112 |
03/24/03 | 19.8 | +0.66% | 10,998 |
End-of-day quote NEO Exchange, June 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+45.82% | 77TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.92% | 25TCr | |
-1.51% | 22TCr | |
+11.28% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr | |
+0.28% | 12TCr |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock